Could fewer dressing changes be safer? trial tests biweekly PICC care for chemo patients

NCT ID NCT07697170

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial compares changing the dressing on a PICC line (a type of central catheter) every week versus every two weeks in people with colon or pancreas cancer receiving chemotherapy. The goal is to see if less frequent changes are just as safe, with no increase in skin injuries, infections, or other catheter problems. A total of 150 adults will be followed for up to 24 weeks to measure outcomes like skin damage, bloodstream infections, and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dressing changes for peripherally inserted central catheters
What this could lead to
If biweekly dressing changes prove safe, patients could need fewer clinic visits, reducing burden and healthcare costs.
What could go wrong
This is a small, early-stage trial (150 participants) comparing two care schedules; it does not test a new drug or treatment. Results may not apply to all cancer patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER PANCREAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sandra Cabrera Jaime

    Badalona, Barcelona, 08916, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.